Patent Ductus Arteriosus (PDA) is a congenital cardiovascular anomaly characterized by the persistent patency of the ductus arteriosus, a vital fetal blood vessel that normally closes shortly after birth. This condition leads to abnormal blood flow between the pulmonary artery and the aorta, resulting in the mixing of oxygenated and deoxygenated blood. This can place undue stress on the heart, potentially causing complications such as heart failure if left untreated. Individuals with PDA may exhibit various symptoms, including but not limited to respiratory distress, inadequate weight gain, and an elevated susceptibility to respiratory infections. The clinical presentation can vary, and the severity of symptoms depends on the size of the patent ductus arteriosus. A prompt and accurate diagnosis is essential for effective management. Intervention options range from pharmacological approaches to surgical closure, with the choice depending on factors such as the patient's age, overall health, and the size of the ductus arteriosus. Medications that promote ductal closure or, in more severe cases, surgical procedures to physically seal the ductus arteriosus may be employed.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt